Current Weather
The Spy FM

Ark. Judge Socks Johnson & Johnson With $1.1 Billion Penalty

Filed by KOSU News in Business.
April 11, 2012

A state judge in Arkansas ordered Johnson & Johnson to pay a $1.1 billion fine after a jury found the company had minimized the risks of its antipsychotic drug Risperdal.

Judge Tim Fox determined that J&J and its Janssen Pharmaceuticals unit repeatedly broke the state’s Medicaid fraud law, the Associated Press reports. One big issue: a letter sent to thousands of doctors in the state 2003 that said Risperdal was safer than rival medicines, according to Bloomberg.

Each Risperdal prescription for a Medicaid patient during a 3¬Ĺ-year period represented a violation of state law. Multiply $5,000, the minimum fine, by more than 200,000 prescriptions, and you get the lion’s share of the penalty.

“We are disappointed with the judge’s decision on penalties,” the company said in a statement. J&J is asking for a new trial. If that’s denied, the company will appeal. The company statement said Janssen presented plenty of evidence during the trial to show that it had “acted responsibly and fully complied with all laws and regulations regarding its antipsychotic prescription medication Risperdal.”

The company also faulted the state’s case, saying it hadn’t showed that any Arkansas patients were harmed by Risperdal, or that doctors or the state Medicaid program had been misled. What’s more, J&J says Arkansas Medicaid spent just $8.1 million on Risperdal prescriptions during the period at issue in the trial.

The drug, a so-called second generation antipsychotic, is generic now (as risperidone). But for years it was one of the company’s biggest sellers. In 2007, the drug’s best year, worldwide Risperdal sales hit $4.5 billion.

But Risperdal and drugs like it were linked to weight gain and an increased risk for diabetes in patients taking them.

The Arkansas jury’s decision and the judge’s penalty are just the latest legal setbacks for Risperdal. A South Carolina judge upheld a $327 million penalty against J&J and its Janssen unit late last year. Previously, the judge overseeing the case had called J&J’s behavior in the marketing of the drug “detestable.”

Earlier this year, the company agreed to pay $158 million to settle charges it improperly marketed Risperdal in Texas and caused the state’s Medicaid program to spend too much on the medicine. [Copyright 2012 National Public Radio]

Leave a Reply

4PM to 5PM Weekend All Things Considered

Weekend All Things Considered

Listen Live Now!

5PM to 7PM American Routes

American Routes

Hosted by Nick Spitzer, American Routes is a two-hour weekly excursion into American music, spanning eras and genres—roots rock and soul, blues and country, jazz, gospel and beyond.

View the program guide!

7PM to 9PM The Oklahoma Rock Show

The Oklahoma Rock Show

The Oklahoma Rock Show filters through dozens of submissions a week to find the best in new local music. Ryan LaCroix is the host and mastermind behind the show and teaches at the Academy of Contemporary Music at the University of Central Oklahoma (ACM@UCO).

View the program guide!

Upcoming Events in your area (Submit your event today!)

Streaming audio and podcasts

Stream KOSU on your smartphone

Phone Streaming

SmartPhone listening options on this page are intended for many iPhones, Blackberries, etc. with low-cost software applications available to listen to our full-time web streams, both News on KOSU-1 and Classical on KOSU-2.

Learn more about our complete range of streaming services

We're perfecting the patient experience - Stillwater Medical Center